Retina's Believe It Or Not!
Media formats available:
Details
Presenters
Overview
NoneThis continuing medical education activity is supported through independent educational grants from Regeneron Pharmaceuticals, Inc. and Carl Zeiss Meditec, Inc. Learning Objectives
Upon completion of this activity, the participant should be able to: - Discuss a wide variety of treatment approaches for numerous vitreoretinal disease states
- Compare the most recent monotherapy and combination therapy clinical study evidence using available therapies for AMD, DME, and RVO
- Develop individualized treatment plans for patients with retina disorders that use a combination of imaging, treat and extend, or treat and observe
- Apply case study examples to real world clinical settings
Accreditation
Accreditation Statement Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA Credit Designation Statement Evolve Medical Education LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty and Disclosures
DISCLOSURE POLICY
The following faculty members have the following financial relationships with commercial interests: Caroline R. Baumal, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Genentech, Inc and Stealth BioTherapeutics. Peter Kaiser, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Aerpio Therapeutics; Alcon; Allergan Inc.; Allegro Ophthalmics; Bayer Corporation; Biogen, Inc.; Novartis, Ohr Pharmaceutical, Inc.; Ophthotech Corporation; Regeneron Pharmaceuticals, Inc.; Sanfen Pharmaceutical Company; Shire Plc.; and ThromboGenics NV. Dante J. Pieramici, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan, Inc.; Bayer Corporation and Genentech, Inc. John D. Pitcher, III, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan, Inc.; Genentech, Inc. and Regeneron Pharmaceuticals, Inc. Sunil Srivasta, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Santen Pharmaceutical Co, Ltd. Grant/Research Support: Allergan, Inc. Nathan C. Steinle, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alimera Sciences, Inc.; Genentech, Inc. Notal Vision, Inc.; and Vortex Surgical. Grant/Research Support: Carl Zeiss Meditec, Inc.; Genentech, Inc. and Regeneron Pharmaceuticals, Inc. Editorial Support Disclosure Michelle Dalton, Writer and Cheryl Cavanaugh, MS, Evolve Medical Education LLC have no real or apparent conflicts of interest to report. Rishi P. Singh, MD, Peer Reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon; Allergan Inc.; Carl Zeiss Meditec; Genentech, Inc; Optos; Regeneron Pharmaceuticals, Inc; and Shire Plc. Grant/Research Support: Alcon; Apellis Pharmaceuticals; Genentech, Inc; and Regeneron Pharmaceuticals, Inc.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Disclaimer
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, Regeneron Pharmaceuticals, Inc. or Carl Zeiss Meditec, Inc. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!